Capital Expenditures Guidance for 2025: $375 million to $425 million. Noble Corp PLC (NYSE:NE) reported strong financial results for Q1 2025, with an adjusted EBITDA of $338 million and free cash ...

Net Debt: Rose due to working capital build, expected to unwind through the year. BP PLC (NYSE:BP) achieved strong operational performance with over 96% refining availability and more than 95% ...

Capita today announces that, following approval of the Share Consolidation Resolution at today’s Annual General Meeting, applications have been made to the Financial Conduct Authority (FCA) and, the ...

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each ...

About Jazz Pharmaceuticals Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families.